Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study

BACKGROUND: Sodium zirconium cyclosilicate (SZC; formerly ZS-9) is a selective potassium (K(+)) binder for the treatment of adults with hyperkalaemia. This post hoc analysis of an open-label, single-arm trial (NCT02163499) compared SZC efficacy and safety >12 months among outpatients with hyperka...

Descripción completa

Detalles Bibliográficos
Autores principales: Roger, Simon D, Lavin, Philip T, Lerma, Edgar V, McCullough, Peter A, Butler, Javed, Spinowitz, Bruce S, von Haehling, Stephan, Kosiborod, Mikhail, Zhao, June, Fishbane, Steven, Packham, David K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771984/
https://www.ncbi.nlm.nih.gov/pubmed/32030422
http://dx.doi.org/10.1093/ndt/gfz285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771984/
https://www.ncbi.nlm.nih.gov/pubmed/32030422
http://dx.doi.org/10.1093/ndt/gfz285

Ejemplares similares